Spots Global Cancer Trial Database for pembrolizumab, pemetrexed, platinum
Every month we try and update this database with for pembrolizumab, pemetrexed, platinum cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Prospective Study of Pembrolizumab Combining Chemotherapy in Advanced NSCLC Patients With EGFR Exon 21 Point Mutation. | NCT06142617 | Non Small Cell ... Immune Checkpoi... EGFR Exon 21 Mu... | Pembrolizumab, ... Osimertinib | 18 Years - | Peking Union Medical College Hospital |